Table of Contents Table of Contents
Previous Page  507 692 Next Page
Information
Show Menu
Previous Page 507 692 Next Page
Page Background

[6]

Hollingsworth JM, Rogers MA, Kaufman SR, et al. Medical therapy to facilitate urinary stone passage: a meta-analysis. Lancet 2006;368: 1171–9

.

[7]

Campschroer T, Zhu Y, Duijvesz D, Grobbee DE, Lock MT. Alpha- blockers as medical expulsive therapy for ureteral stones. Cochrane Database Syst Rev 2014:CD008509

.

[8]

Dechartres A, Boutron I, Trinquart L, Charles P, Ravaud P. Single- center trials show larger treatment effects than multicenter trials: evidence from a meta-epidemiologic study. Ann Intern Med 2011; 155:39–51

.

[9]

Flather MD, Farkouh ME, Pogue JM, Yusuf S. Strengths and limita- tions of meta-analysis: larger studies may be more reliable. Control Clin Trials 1997;18:568–79, discussion 661-6

.

[10]

Wang H, Man LB, Huang GL, Li GZ, Wang JW. Comparative efficacy of tamsulosin versus nifedipine for distal ureteral calculi: a meta- analysis. Drug Des Devel Ther 2016;10:1257–65.

[11]

O¨ zsoy M, Liatsikos E, Scheffbuch N, Kallidonis P. Comparison of silodosin to tamsulosin for medical expulsive treatment of ureteral stones: a systematic review and meta-analysis. Urolithiasis 2016; 44:491–7.

[12]

Pickard R, Starr K, MacLennan G, et al. Medical expulsive therapy in adults with ureteric colic: a multicentre, randomised, placebo- controlled trial. Lancet 2015;386:341–9.

[13]

Furyk JS, Chu K, Banks C, et al. Distal ureteric stones and tamsulosin: a double-blind, placebo-controlled, randomized, multicenter trial. Ann Emerg Med 2016;67:86–9500.

[14]

Sur RL, Shore N, L’Esperance J, et al. Silodosin to facilitate passage of ureteral stones: a multi-institutional, randomized, double-blinded, placebo-controlled trial. Eur Urol 2015;67:959–64

.

[15]

Preminger GM, Tiselius HG, Assimos DG, et al. 2007 Guideline for the management of ureteral calculi. Eur Urol 2007;52:1610–31.

[16]

Assimos D, Krambeck A, Miller NL, et al. Surgical management of stones: American Urological Association/Endourological Society guideline, part II. J Urol 2016;196:1161–9

.

[17] OCEBM Levels of Evidence Working Group. The Oxford levels of

evidence 2. Oxford Centre for Evidence-Based Medicine Web site.

http://www.cebm.net/index.aspx?o=5653 .

[18]

Turk C, Petrik A, Sarica K, et al. EAU guidelines on diagnosis and conservative management of urolithiasis. Eur Urol 2016;69: 468–74.

[19] Turk C, Knoll T, Petrik A, et al. Guidelines on urolithiasis. European

Association of Urology Web site.

https://uroweb.org/guideline/ urolithiasis/ .

[20]

Pogue J, Yusuf S. Overcoming the limitations of current meta- analysis of randomised controlled trials. Lancet 1998;351: 47–52.

E U R O P E A N U R O L O G Y 7 1 ( 2 0 1 7 ) 5 0 4 – 5 0 7

507